Literature DB >> 24532416

The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience.

Elchanan Bruckheimer1, Max Godfrey, Tamir Dagan, Michael Levinzon, Gabriel Amir, Einat Birk.   

Abstract

OBJECTIVES: To present our initial experience with the Amplatzer Duct Occluder II Additional Sizes (ADOIIAS) device.
BACKGROUND: The ADOIIAS is a modified PDA closure device of various lengths and widths with small disks to avoid flow disturbance in the pulmonary arteries and descending aorta. PATIENT POPULATION: All patients who underwent attempted closure with an ADOIIAS device at our institution CATHETERIZATION: Following aortography the PDA was closed using a 4-5Fr delivery system from the pulmonary or aortic side with an ADOIIAS. Aortography to confirm position and leak was performed before and after device release. Echocardiography was performed before discharge the following day.
RESULTS: Between June 2011 and December 2012, 60 patients [33 female], median age 3.3 yrs [0.6-15.8 years], and weight 14.5 kg [4-79] underwent attempted PDA closure with an ADOIIAS device. 56/60 [93.3%] ADOIIAS devices were successfully deployed [52 aortic side]. In 55/56 [98.2%], the PDA was closed on follow up echocardiogram usually on the next day. In one case, there was a small residual PDA of no hemodynamic significance on follow up. In four cases, the ADOIIAS was unstable, including one device embolization which was retrieved with no sequelae, and the PDA was closed in all cases with an alternative device in the same procedure. The mean ratio of ADOIIAS height:PDA pulmonary diameter was 2.4 ± 0.5:1.
CONCLUSIONS: We report a large single-center experience with the new ADOIIAS device which proved to be versatile, safe, effective, and easy to use in the appropriate ductal anatomy.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital heart defects; patent ductus arteriosus; pediatric intervention

Mesh:

Year:  2014        PMID: 24532416     DOI: 10.1002/ccd.25445

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

1.  Transcatheter Closure of Arterial Duct in Infants < 6 kg: Amplatzer Duct Occluder Type I vs Amplatzer Duct Occluder II Additional Sizes.

Authors:  Giuseppe Santoro; Mario Giordano; Gianpiero Gaio; Maria Teresa Palladino; Giovanbattista Capozzi; Carola Iacono; Maria Giovanna Russo
Journal:  Pediatr Cardiol       Date:  2018-02-17       Impact factor: 1.655

2.  Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units: Analysis of data from the Pediatric Health Information Systems Database.

Authors:  Michael L O'Byrne; Marisa E Millenson; Connor B Grady; Jing Huang; Nicolas A Bamat; David A Munson; Lihai Song; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2019-08-17       Impact factor: 4.749

3.  Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications.

Authors:  Carl H Backes; Sharon L Cheatham; Grace M Deyo; Scott Leopold; Molly K Ball; Charles V Smith; Vidu Garg; Ralf J Holzer; John P Cheatham; Darren P Berman
Journal:  J Am Heart Assoc       Date:  2016-02-12       Impact factor: 5.501

Review 4.  Recent advances in pediatric interventional cardiology.

Authors:  Seong-Ho Kim
Journal:  Korean J Pediatr       Date:  2017-08-14

Review 5.  Translation in cardiovascular stents and occluders: From biostable to fully degradable.

Authors:  Yingying Huang; Yee Shan Wong; Herr Cheun Anthony Ng; Freddy Y C Boey; Subbu Venkatraman
Journal:  Bioeng Transl Med       Date:  2017-07-19

6.  Transcatheter closure of PDA in premature babies less than 2 kg.

Authors:  Nazmi Narin; Özge Pamukçu; Ali Baykan; Mustafa Argun; Abdullah Özyurt; Adnan Bayram; Kazım Üzüm
Journal:  Anatol J Cardiol       Date:  2016-09-02       Impact factor: 1.596

7.  Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams.

Authors:  Shyam K Sathanandam; Dan Gutfinger; Laura O'Brien; Thomas J Forbes; Matthew J Gillespie; Darren P Berman; Aimee K Armstrong; Shabana Shahanavaz; Thomas K Jones; Brian H Morray; Toby A Rockefeller; Henri Justino; David G Nykanen; Evan M Zahn
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-20       Impact factor: 2.692

8.  Fate of the Left Pulmonary Artery and Thoracic Aorta After Transcatheter Patent Ductus Arteriosus Closure in Low Birth Weight Premature Infants.

Authors:  Dor Markush; Jennifer C Tsing; Surbhi Gupta; Nicole C Berndsen; Geena Radville; Ruchira Garg; Evan M Zahn; Myriam Almeida-Jones
Journal:  Pediatr Cardiol       Date:  2021-01-04       Impact factor: 1.655

9.  Trans-Catheter Closure of Patent Ductus Arteriosus, which device should we use?

Authors:  Rym Gribaa; Sami Ouannes; Heithem Tangour; Sameh Ben Farhat; Houssem Thabet; Mehdi Slim; Aymen Elheraiche; Elyes Neffati
Journal:  Tunis Med       Date:  2021 Novembre

10.  Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).

Authors:  Kewal Kanabar; Dinakar Bootla; Navjyot Kaur; C R Pruthvi; Darshan Krishnappa; Krishna Santosh; Vivek Guleria; Manoj Kumar Rohit
Journal:  Indian Heart J       Date:  2020-04-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.